About 3,930,000 results
Open links in new tab
  1. Adstiladrin: Uses, Dosage, Side Effects & Warnings - Drugs.com

    Dec 9, 2024 · Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer. …

  2. Bladder Cancer Treatment Options

    ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non …

  3. Clinical overview Indication: ADSTILADRIN® (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients …

  4. First Bladder Cancer Patient Dosed with Commercially Available ...

    Sep 12, 2023 · ADSTILADRIN ® (nadofaragene firadenovec-vncg) is the first and only FDA-approved intravesical gene therapy for the treatment of adult patients with high-risk Bacillus …

  5. FDA Approval Summary: Nadofaragene Firadenovec-vncg for …

    Apr 1, 2025 · Abstract On December 16, 2022, the FDA approved the adenoviral vector-based gene therapy nadofaragene firadenovec-vncg (brand name Adstiladrin) for the treatment of …

  6. Adstiladrin (Nadofaragene Firadenovec-Vncg) for bladder cancer

    Adstiladrin is also called nadofaragene firadenovec-vncg. Adstiladrin is a gene therapy that uses a non-replicating adenoviral vector (a modified virus that cannot multiply) to deliver a gene to …

  7. ADSTILADRIN® is indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in …

  8. Nadofaragene Firadenovec-vncg (Adstiladrin®- Given into the bladder

    Dec 18, 2024 · Nadofaragene Firadenovec-vncg is a non-replicating adenoviral vector-based gene therapy. The treatment delivers the human interferon alfa-2b gene, which is non …

  9. Anyone treated with Adstiladrin for BCG-unresponsive bladder cancer?

    Jul 22, 2024 · As you likely know, Adstiladrin (nadofaragene firadenovec-vncg) was recently approved for bladder cancer. It is a gene therapy currently used for adult patients with high …

  10. Nadofaragene firadenovec uses a recombinant adenovirus that encodes for interferon alpha-2b gene. Intravesical instillation of interferon alone for bladder cancer produced complete …